360 related articles for article (PubMed ID: 33370485)
1. Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment.
Sagar R; Mackie S; W Morgan A; Stewart P; Abbas A
Clin Endocrinol (Oxf); 2021 Mar; 94(3):361-370. PubMed ID: 33370485
[TBL] [Abstract][Full Text] [Related]
2. PREDICTING RECOVERY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AFTER PROLONGED GLUCOCORTICOID USE.
Leong SH; Shander S; Ratnasingam J
Endocr Pract; 2018 Jan; 24(1):14-20. PubMed ID: 29368966
[TBL] [Abstract][Full Text] [Related]
3. Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary-adrenal axis in post-penetrating keratoplasty patients?
Sandhu SS; Smith JM; Doherty M; James A; Figueiredo FC
Eye (Lond); 2012 May; 26(5):699-702. PubMed ID: 22344184
[TBL] [Abstract][Full Text] [Related]
4. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.
Woods CP; Argese N; Chapman M; Boot C; Webster R; Dabhi V; Grossman AB; Toogood AA; Arlt W; Stewart PM; Crowley RK; Tomlinson JW
Eur J Endocrinol; 2015 Nov; 173(5):633-42. PubMed ID: 26294794
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management.
Karangizi AHK; Al-Shaghana M; Logan S; Criseno S; Webster R; Boelaert K; Hewins P; Harper L
BMC Nephrol; 2019 May; 20(1):154. PubMed ID: 31060510
[TBL] [Abstract][Full Text] [Related]
6. Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non-ACTH-Secreting Macroadenomas.
Pofi R; Gunatilake S; Macgregor V; Shine B; Joseph R; Grossman AB; Isidori AM; Cudlip S; Jafar-Mohammadi B; Tomlinson JW; Pal A
J Clin Endocrinol Metab; 2019 Nov; 104(11):5316-5324. PubMed ID: 31225871
[TBL] [Abstract][Full Text] [Related]
7. The Short Synacthen (Corticotropin) Test Can Be Used to Predict Recovery of Hypothalamo-Pituitary-Adrenal Axis Function.
Pofi R; Feliciano C; Sbardella E; Argese N; Woods CP; Grossman AB; Jafar-Mohammadi B; Gleeson H; Lenzi A; Isidori AM; Tomlinson JW
J Clin Endocrinol Metab; 2018 Aug; 103(8):3050-3059. PubMed ID: 29846658
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis suppression - The value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery.
Kalaria T; Agarwal M; Kaur S; Hughes L; Sharrod-Cole H; Chaudhari R; Gherman-Ciolac C; Chopra R; Okeke V; Ford C; Buch H; Gama R
Ann Clin Biochem; 2020 Nov; 57(6):456-460. PubMed ID: 32961064
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.
Abdu TA; Elhadd TA; Neary R; Clayton RN
J Clin Endocrinol Metab; 1999 Mar; 84(3):838-43. PubMed ID: 10084558
[TBL] [Abstract][Full Text] [Related]
11. Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance test.
Kane KF; Emery P; Sheppard MC; Stewart PM
QJM; 1995 Apr; 88(4):263-7. PubMed ID: 7796076
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
14. An update on the biochemical diagnosis of congenital ACTH insufficiency.
Mehta A; Hindmarsh PC; Dattani MT
Clin Endocrinol (Oxf); 2005 Mar; 62(3):307-14. PubMed ID: 15730412
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
[TBL] [Abstract][Full Text] [Related]
16. "A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.
Mathara Diddhenipothage SAD; Beck KJ; Loo H; Amiyangoda GK; Pofi R; Tomlinson JW; Pal A
Clin Endocrinol (Oxf); 2023 Aug; 99(2):142-151. PubMed ID: 37288515
[TBL] [Abstract][Full Text] [Related]
17. Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study.
Sacre K; Dehoux M; Chauveheid MP; Chauchard M; Lidove O; Roussel R; Papo T
J Clin Endocrinol Metab; 2013 Aug; 98(8):3199-205. PubMed ID: 23760625
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency.
Maguire AM; Biesheuvel CJ; Ambler GR; Moore B; McLean M; Cowell CT
Clin Endocrinol (Oxf); 2008 May; 68(5):683-91. PubMed ID: 18070143
[TBL] [Abstract][Full Text] [Related]
19. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
Courtney CH; McAllister AS; McCance DR; Bell PM; Hadden DR; Leslie H; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
[TBL] [Abstract][Full Text] [Related]
20. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
Suliman AM; Smith TP; Labib M; Fiad TM; McKenna TJ
Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
